No association between serotonin-2A receptor gene polymorphism and psychotic symptomatology of mood disorders

Psychiatry Research

Volumn 86, Issue 3, 1999, Pages 203-209

  Serretti, Alessandro ^a   Lilli, Roberta ^a   Lorenzi, Cristina ^a,b   Smeraldi, Enrico ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Bipolar disorder; Delusions; Disorganization; Genetics; Major depressive disorder

Indexed keywords

SEROTONIN; SEROTONIN 2A RECEPTOR;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; ALLELES; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEVERITY OF ILLNESS INDEX;

EID: 0032813280     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00032-3     Document Type: Article

References (58)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th edn:1994;American Psychiatric Press, Washington DC.
2. Andreasen N.C., Arndt S., Alliger R., Miller D., Flaum M. Symptoms of schizophrenia. Methods, meanings, and mechanisms. Archives of General Psychiatry. 52:1995;341-351.
3. Arranz M.J., Lin M.W., Powell J., Kerwin R., Collier D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1831-1832.
4. Arranz M.J., Erdmann J., Kirov G., Rietschel M., Sodhi M., Albus M., Ball D., Maier W., Davies N., Franzek E., Abusaad I., Weigelt B., Murray R., Shimron-Abarbanell D., Kerwin R., Propping P., Sham P., Nöthen M.M., Collier D.A. 5-HT2A receptor and bipolar affective disorder: association studies in affected patients. Neuroscience Letters. 224:1997;95-98.
5. Barbujani G., Sokal R.R. Genetic population structure of Italy. I. Geographic patterns of gene frequencies. Human Biology. 63:1991;253-272.
6. Benkelfat C. Serotoninergic mechanisms in psychiatric disorders: new research tools, new ideas. International Clinical Psychopharmacology. 8:1993;53-56.
7. Bradley C., Blakely R. Alternative splicing of the human serotonin transporter gene. Journal of Neurochemistry. 69:1997;1356-1367.
8. Burke J.G., Murphy B.M., Bray J.C., Walsh D., Kendler K.S. Clinical similarities in siblings with schizophrenia. American Journal of Medical Genetics. 67:1996;239-243.
9. Chen C.H., Lee Y.R., Wei F.C., Koong F.J., Hwu H.G., Hsiao K.J. Lack of allelic association between 102T/C polymorphism of serotonin receptor type 2A gene and schizophrenia in Chinese. Psychiatric Genetics. 7:1997;35-38.
10. Chua S.E., Wright I.C., Poline J.B., Liddle P.F., Murray R.M., Frackowiak R.S., Friston K.J., McGuire P.K. Grey matter correlates of syndromes in schizophrenia. A semi-automated analysis of structural magnetic resonance images. British Journal of Psychiatry. 170:1997;406-410.
11. Cloninger C. Turning point in the design of linkage studies of schizophrenia. American Journal of Medical Genetics. 54:1994;83-92.
12. Cloninger C., Adolfsson R., Svrakic N. Mapping genes for human personality. Nature Genetics. 12:1996;3-4.
13. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 1988;Lawrence Erlbaum Associates, Publishers, Hillsdale, NJ.
14. Comings D. Polygenic inheritance in psychiatric disorders. Blum K., Noble E.P. Handbook of Psychiatric Genetics. 1997;235-260 CRC Press, Boca Raton FL.
15. Coryell W., Winokur G., Shea T., Maser J., Endicott J., Akiskal H. The long-term stability of depressive subtypes. American Journal of Psychiatry. 151:1994;199-204.
16. Erdmann J., Shimron-Abarbanell D., Rietschel M., Albus M., Maier W., Korner J., Bondy B., Chen K., Shih J.C., Knapp M., Propping P., Nöthen M.M. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Human Genetics. 97:1996;614-619.
17. Fuciarelli M., Vienna A., Paba E., Bastianini A., Sansonetti B., Capucci E., Destefano G.F. PI, GC, HP, and TF serum protein polymorphisms in Siena, Tuscany, Italy, with a review of data for Italy. American Journal of Human Biology. 9:1997;629-646.
18. Gasparini P., Estivill X., Volpini V., Totaro A., Castellvi-Bel S., Govea N., Mila M., Della Monica M., Ventruto V., De Benedetto M., Stanziale P., Zelante L., Mansfield E.S., Sandkuijl L., Surrey S., Fortina P. Linkage of DFNB1 to non-syndromic neurosensory autosomal-recessive deafness in Mediterranean families. European Journal of Human Genetics. 5:1997;83-88.
19. Ginsburg B., Werick T., Escobar J., Kugelmass S. Molecular genetics of psychopathologies: a search for simple answers to complex problems. Behavior Genetics. 26:1996;325-333.
20. Gutierrez B., Bertranpetit J., Collier D., Arranz M.J., Valles V., Guillamat R., Van Os J., Fananas L. Genetic variation of the 5-HT2A receptor gene and bipolar affective disorder. Human Genetics. 100:1997;582-584.
21. Hawi Z., Myakishev M.V., Straub R.E., Kendler K.S., Walsh D., Gill M. No association or linkage between the 5-HT2a/T102C polymorphism and schizophrenia in Irish families. American Journal of Medical Genetics. 74:1997;370-373.
22. Inayama Y., Yoneda H., Sakai T., Ishida T., Nonomura Y., Kono Y., Takahata R., Koh J., Sakai J., Takai A., Inada Y., Asaba H. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. American Journal of Medical Genetics. 67:1996;103-105.
23. Ishigaki T., Xie D.W., Liu J.C., Nakamura Y., Zhang H.Y., Tani K., Shimazu Y., Chen K., Shih J.C., Miyasato K., Ohara K. Intact 5-HT2A receptor exons and the adjoining intron regions in schizophrenia. Neuropsychopharmacology. 14:1996;339-347.
24. Jacobs B.L., Fornal C.A. Serotonin and behavior. A general hypothesis. Bloom F.E., Kupfer D.J. Psychopharmacology: The Fourth Generation of Progress. 1995;461-469 Raven Press, New York.
25. Jönsson E., Nöthen M.M., Bunzel R., Propping P., Sedvall G. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1831.
26. Kendler K.S., Karkowski-Shuman L., O'Neill F.A., Straub R.E., MacLean C.J., Walsh D. Resemblance of psychotic symptoms and syndromes in affected sibling pairs from the Irish Study of High-Density Schizophrenia Families: evidence for possible etiologic heterogeneity. American Journal of Psychiatry. 154:1997;191-198.
27. Lahiri D., Nurnberger J.J. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Research. 19:1991;5444.
28. Leckman J.F., Sholomskas D., Thompson W.D., Belanger A., Weissman M.M. Best estimate of lifetime psychiatric diagnosis: a methodological study. Archives of General Psychiatry. 39:1982;879-883.
29. Liddle P.F. The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. British Journal of Psychiatry. 151:1987;145-151.
30. Liddle P.F., Barnes T.R.E. Syndromes of chronic schizophrenia. British Journal of Psychiatry. 157:1990;558-561.
31. Loftus J., DeLisi L.E., Crow T.J. Familial associations of subsyndromes of psychosis in affected sibling pairs with schizophrenia and schizoaffective disorder. Psychiatry Research. 80:1998;101-111.
32. Mahieu B., Souery D., Lipp O., Mendelbaum K., Verheyen G., De Maertelaer V., Van Broeckhoven C., Mendlewicz J. No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism. Psychiatry Research. 70:1997;65-69.
33. Malhotra A.K., Goldman D., Buchanan R., Breier A., Pickar D. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1830-1831.
34. Maziade M., Roy M.A., Martinez M., Cliche D., Fournier J.P., Garneau Y., Nicole L., Montgrain N., Dion C., Ponton A.M. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. American Journal of Psychiatry. 152:1995;1458-1463.
35. Maziade M., Bouchard S., Gingras N., Charron L., Cardinal A., Roy M.A., Gauthier B., Tremblay G., Cote S., Fournier C., Boutin P., Hamel M., Merette C., Martinez M. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome. British Journal of Psychiatry. 169:1996;371-378.
36. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry. 48:1991;764-770.
37. Peralta V., de Leon J., Cuesta M.J. Are there more than two syndromes in schizophrenia? A critique of the positive-negative dichotomy. British Journal of Psychiatry. 161:1992;335-343.
38. Peralta V., Cuesta M., De Leon J. An empirical analysis of latent structures underlying schizophrenic symptoms: a four-syndrome model. Biological Psychiatry. 36:1994;726-736.
39. Risch N. Linkage strategies for genetically complex traits: I. Multilocus models. American Journal of Medical Genetics. 46:1990;222-228.
40. Sasaki T., Hattori M., Fukuda R., Kunugi H., Nanko S. 5HT 2a receptor T102C polymorphism and schizophrenia. Lancet. 347:1996;1832.
41. Serretti A., Macciardi F., Smeraldi E. Identification of symptomatologic patterns common to major psychoses: proposal for a phenotype definition. American Journal of Medical Genetics. 67:1996;393-400.
42. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Di Bella D., Catalano M., Smeraldi E. GABAA Alpha-1 subunit gene not associated with depressive symptomatology in mood disorders. Psychiatric Genetics. 8:1998;251-254.
43. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Smeraldi E. Dopamine receptor D-4 gene is associated with delusional symptomatology in mood disorders. Psychiatry Research. 80:1998;129-136.
44. Serretti A., Macciardi F., Smeraldi E. Dopamine receptor D2 Ser Cys311 variant associated with disorganized symptomatology of schizophrenia. Schizophrenia Research. 34:1998;207-210.
45. Serretti A., Macciardi F., Verga M., Cusin C., Pedrini S., Smeraldi E. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. American Journal of Medical Genetics. 81:1998;127-130.
46. Serretti A., Catalano M., Smeraldi E. Serotonin transporter gene is not associated with symptomatology of schizophrenia. Schizophrenia Research. 35:1999;33-39.
47. Serretti A., Macciardi F., Cusin C., Lattuada E., Lilli R., Bella D.D., Catalano M., Smeraldi E. No interaction of GABA(A) alpha-1 subunit and dopamine receptor D4 exon 3 genes in symptomatology of major psychoses. American Journal of Medical Genetics. 88:1999;44-49.
48. Souery D., Lipp O., Serretti A., Mahieu B., Rivelli S.K., Cavallini C., Ackenheil M., Adolfsson R., Aschauer H., Blackwood D., Dam H., Verheyen G., Delcoigne B., Demartelaer V., Dikeos D., Fuchshuber S., Heiden M., Jabelensky A., Kokovljevic M., Kessing L., Lerer B., Macedo A., Mellerup T., Milanova V., Muir W., Nylander P.O., Onchev G., Oruc L., Papadimitrou G.N., Pekkarinen P., Peltonen L., Pinto de Azevedo M.H., Pull C., Shapira B., Smeraldi E., Staner L., Stefanis C., Verga M., Raeymaekers P., Macciardi F., Van Broeckhoven C., Mendelwicz J. European Collaborative Project on Affective Disorders: interactions between genetic and psychosocial vulnerability factors. Psychiatric Genetics. 8:1998;197-206.
49. Spurlock G., Heils A., Holmans P., Williams J., D'Souza U.M., Cardno A., Murphy K.C., Jones L., Buckland P.R., McGuffin P., Lesch K.P., Owen M.J. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter. Molecular Psychiatry. 3:1998;42-49.
50. Tay A.H., Lim L.C., Lee W.L., Wong K.E., Wong L.Y., Tsoi W.F. Association between allele 1 of T102C polymorphism, 5-hydroxytryptamine 2a receptor gene and schizophrenia in Chinese males in Singapore. Human Heredity. 47:1997;298-300.
51. Toth M. Transcriptional regulation of the 5-HT2A receptor. Behavioural Brain Research. 73:1996;183-186.
52. Tsuang M., Faraone S. The Genetics of Mood Disorders. 1990;The Johns Hopkins University Press, Baltimore.
53. Van Os J., Fahy T.A., Jones P., Harvey I., Sham P., Lewis S., Bebbington P., Toone B., Williams M., Murray R. Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychological Medicine. 26:1996;161-176.
54. Van Os J., Marcelis M., Sham P., Jones P., Gilvarry K., Murray R. Psychopathological syndromes and familial morbid risk of psychosis. British Journal of Psychiatry. 170:1997;241-246.
55. Verga M., Macciardi F., Cohen S., Pedrini S., Smeraldi E. No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. American Journal of Medical Genetics. 74:1997;21-25.
56. Williams J., Spurlock G., McGuffin P., Mallet J., Nöthen M.M., Gill M., Aschauer H., Nylander P.O., Macciardi F., Owen M.J. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet. 347:1996;1294-1296.
57. Winokur G., Coryell W., Endicott J., Akiskal H. Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). American Journal of Psychiatry. 150:1993;1176-1181.
58. Zhang H.Y., Ishigaki T., Tani K., Chen K., Shih J.C., Miyasato K., Ohara K., Ohara K. Serotonin2A receptor gene polymorphism in mood disorders. Biological Psychiatry. 41:1997;768-773.